We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals

421 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 131 increasing their positions, 161 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $486M | Put options by funds: $346M

0.93% less ownership

Funds ownership: 94.83%93.9% (-0.93%)

5% less funds holding

Funds holding: 443421 (-22)

11% less capital invested

Capital invested by funds: $18.6B → $16.5B (-$2.08B)

19% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 161

19% less first-time investments, than exits

New positions opened: 55 | Existing positions closed: 68

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
421
Holders Change
-22
Holders Change %
-4.97%
% of All Funds
7.09%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
55
Increased
131
Reduced
161
Closed
68
Calls
$486M
Puts
$346M
Net Calls
+$139M
Net Calls Change
+$195M